| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Feb 20, 2025 | Neumora Therapeutics, Inc. | President | Sell | 41.3 | -8,048 | -3.59% | ✓ | $13.5K |
| Aug 27, 2024 | Aug 27, 2024 | Neumora Therapeutics, Inc. | CFO | Sell | 32.5 | -15,693 | -6.55% | ✓ | $178.8K |
| Aug 22, 2024 | Aug 26, 2024 | Neumora Therapeutics, Inc. | CFO | Sell | 7.5 | -84,307 | -26.02% | ✓ | $984.1K |